Evidence-Based Medicine Guidelines
Selective noradrenaline reuptake inhibitors for schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Selective Noradrenaline Reuptake Inhibitors for Schizophrenia." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305215/all/Selective_noradrenaline_reuptake_inhibitors_for_schizophrenia.
Selective noradrenaline reuptake inhibitors for schizophrenia. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305215/all/Selective_noradrenaline_reuptake_inhibitors_for_schizophrenia. Accessed October 14, 2024.
Selective noradrenaline reuptake inhibitors for schizophrenia. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305215/all/Selective_noradrenaline_reuptake_inhibitors_for_schizophrenia
Selective Noradrenaline Reuptake Inhibitors for Schizophrenia [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305215/all/Selective_noradrenaline_reuptake_inhibitors_for_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Selective noradrenaline reuptake inhibitors for schizophrenia
ID - 1305215
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305215/all/Selective_noradrenaline_reuptake_inhibitors_for_schizophrenia
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
